Skip to main content
. 2023 Dec 8;27(1):108643. doi: 10.1016/j.isci.2023.108643

Table 4.

Metabolites that discriminate between Veillonella treatment and baseline and/or placebo

Metabolite Classification Δ vs. Baseline (VIP Score) Δ vs. Placebo (VIP Score)
2-Piperidinone -Derivative of piperidine (and other natural alkaloids)
-Found in foods
None Decrease (1.96)
Alanine/Sarcosine Amino acid Decrease (2.63) Decrease (1.99)
Aspartic Acid Amino acid Decrease (1.24) None
Betaine Osmolytes
-Found in foods
None Decrease (3.41)
Cadaverine Polyamine Decrease (1.14) None
Citric Acid Aerobic metabolism intermediate
-Found in foods
Increase (1.68) None
Glutamine Amino acid Decrease (1.42) Decrease (1.60)
Leucine Amino acid None Decrease (6.13)
Lysine Amino acid Decrease (1.32) None
Nicotinic/Picolinic Acid Tryptophan metabolite, vitamin B3
-Found in foods
Increase (2.03) None
Pipecolic Acid Piperidine derivative (and other natural alkaloids) that assists in absorption of ions in the small intestine
-Found in foods
Decrease (2.56) Decrease (2.15)
Suberic Acid Derivative of oleic acid
-Found in foods
Decrease (1.15) None
Threonine Amino acid Decrease (1.19) None
Tyrosine Amino acid None Decrease (2.60)

VIP, variable importance in projection scores.